Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

µµ´¢À±È°Á¦°¡ Bacillus Calmette-GuerinÀÇ È¿°ú¿¡ ¹ÌÄ¡´Â ¿µÇâ The Effect of Lubricant on the Viabillty of Bacillus Calmette-Guerin

´ëÇѺñ´¢±â°úÇÐȸÁö 1998³â 39±Ç 7È£ p.651 ~ 655
Ç㸸¿ì, ¼ÛÈ£¿¬, ¾È»ó¹¬,
¼Ò¼Ó »ó¼¼Á¤º¸
Ç㸸¿ì (  ) 
¼øõÇâ´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç

¼ÛÈ£¿¬ (  ) 
¼øõÇâ´ëÇб³ ÀÇ°ú´ëÇÐ ¹Ì»ý¹°Çб³½Ç
¾È»ó¹¬ (  ) 
¼øõÇâ´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç

Abstract

¼­·Ð
¹æ±¤ÀÌÇ༼Æ÷¾Ï¿¡¼­ÀÇ ¹æ±¤³» bacillus CalmetteGuerin(BCG)ÁÖÀÔ¿ä¹ýÀº ±¤¹üÀ§ÇÑ ÀÓ»óÀû
½Ãµµ¿¡¼­ ±¹¼Ò ¸é¿ªÄ¡·á·Î¼­ ¼¼Æ÷ µ¶¼º¹°ÁúÀÇ ¹æ±¤³»ÁÖÀÔÀÇ ¿ì¼ö¼ºÀÌ ÀÔÁõµÇ¾ú´Ù. BCG´Â
¹æ±¤¿¡¼­ ¿°Áõ¹ÝÀÀÀ» À¯¹ßÇϴµ¥ ÀÌ°ÍÀº ±¹¼Ò Ç×Á¾¾ç¼º ¹ÝÀÀ°ú ¿¬°üµÇ´Â °ÍÀ¸·Î °£Áֵǰí,
¹æ±¤³» BCGÁÖÀÔ¿ä¹ýÀÇ È¿°ú´Â BCGÀÇ »ýÁ¸·Â°ú °ü·ÃµÇ¾î ÀÖ´Ù. KelleyµîÀº Ç¥À缺 ¹æ±¤¾Ï
ȯÀÚ¿¡¼­ ¹æ±¤³» BCGÀÇ »ýÁ¸·ÂÀÌ À¯ÀÇÇÏ°Ô Â÷ÀÌ°¡ ÀÖÀ¸¸ç BCG ¹æ±¤³»ÁÖÀÔ¿ä¹ý ÈÄ ÁÖÀÔµÈ
»ì¾ÆÀÖ´Â BCGÀÇ »ýÁ¸·ÂÀÌ ³ô¾Ò´ø ȯÀÚ¿¡¼­ Ä¡·á°á°ú°¡ ¿ì¼öÇß´Ù°í º¸°íÇÏ¿´´Ù. Bohle µîÀº
½ÇÇèÀûÀ¸·Î ¹æ±¤¾Ï¿¡ ´ëÇÑ ¸é¿ª¿ä¹ý¿¡¼­ BCG¿¡ ÀÇÇØ È°¼ºÈ­µÈ killer cellÀÇ À¯µµ¿¡ ÇÊ¿äÇÑ
»ì¾Æ ÀÖ´Â BCGÀÇ È¿°úÀûÀÎ ÀûÁ¤·®À» Á¤¸³ÇÑ ¹Ù ÀÖ´Ù. ÀÌ·¯ÇÑ »ç½ÇÀº ¹æ±¤³» BCGÁÖÀÔ¿¡
ÀÇÇÑ ¸é¿ª¿ä¹ý¿¡¼­ ÁÖÀÔµÈ BCGÀÇ »ýÁ¸·Â°ú »ý±ÕÀÇ ¼ö´Â ÀÓ»óÀûÀ¸·Î Àǹ̰¡ ÀÖ´Ù´Â »ç½ÇÀ»
¸»ÇØ ÁØ´Ù. BCGÀÇ ¹æ±¤³»ÁÖÀԽà ¿äµµÀÇ ¼Õ»óÀ» ÁÙÀ̱â À§ÇØ ÀϹÝÀûÀ¸·Î À±È°Á¦¸¦ »ç¿ëÇÏ
¸ç, ÀÌ¿¡´Â ÀϹÝÀûÀ¸·Î Ç×±Õ¹°ÁúÀÌ Æ÷ÇԵǾî Àִµ¥ ÀÌ°ÍÀÌ BCG¿Í È¥ÇյǾúÀ» ¶§ BCGÀÇ
»ýÁ¸À» ¾ïÁ¦ÇÏ¿© ¹æ±¤³» ¿¡¼­ ¸é¿ª¹Ý¿ËÀ» ÀúÇϽÃų ¼ö ÀÖ´Ù. ÀÌ¿¡ ÀúÀÚ´Â µµ´¢½Ã ¹æ±¤³»·Î
À¯À﵃ ¼ö ÀÖ´Â À±È°Á¦°¡ BCGÀÇ »ýÁ¸·Â¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ÁÒ»çÇϱâ À§ÇØ BCG¿Í À±È°Á¦¸¦
¿©·¯ Á¶°Ç¿¡¼­ ¹è¾çÇÏ¿© ±× °á°ú¸¦ ºñ±³ÇÏ¿´´Ù.
#ÃÊ·Ï#
Purpose : Intravesical instillation of bacillus Calmette-Guerin(BCG) is an established
and effective therapy for the superficial bladder carcinoma. The viability of BCG is
crucial for the induction of a local immune response as well as effective therapy of
recurrent superfical bladder carcinoma. Lubricants are used to facilitate catheterization
during intravesical instillation of BCG. Moreover bacteriostatic components contained in
them have potential to reduce the viability of the BCG. To verify this assumption,
inhibitory effect of four commercially available lubricants on the BCG growth was
analyzed. Materials and Methods : Four different lubricants and their components were
co-incubated with Connaught strain BCG and the resultant growth of BCG was
assessed.
Results : Significant impairment of BCG viability with lubricants was noted.
Chlorhexidine digluconate which is the component of lubricant was considered as
responsible for this inhibition.
Conclusions : During intravesical BCG, lubricants might reduce the number of viable
BCG in clinical use. For this reason, during intravesical immunotherapy with BCG small
amounts of lubricants should be used for urethral catheterization and use of lubricant
which does not contain bacteriostatic agent should be considered. (Korean J Urol 1998;
39: 651 ¡­5)

Å°¿öµå

Lubricants; Bacillus Calmette-Guerin; Bladder carcinoma; Catheterization;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS